Original Research

Published on 23 Aug 2021

Impact of Smoking History on Response to Immunotherapy in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

in Thoracic Oncology

Wenhua Zhao
Wei Jiang
Huilin Wang
Jianbo He
Cuiyun Su
Qitao Yu

Frontiers in Oncology

doi 10.3389/fonc.2021.703143

7,534 views
36 citations

Mini Review

Published on 23 Aug 2021

Targeted Therapy for RET Fusion Lung Cancer: Breakthrough and Unresolved Issue

in Thoracic Oncology

Shinkichi Takamori
Taichi Matsubara
Naoki Haratake
Gouji Toyokawa
Takatoshi Fujishita
Ryo Toyozawa
Kensaku Ito
Masafumi Yamaguchi
Kenichi Taguchi
Tatsuro Okamoto

Frontiers in Oncology

doi 10.3389/fonc.2021.704084

9,197 views
12 citations

Review

Published on 19 Aug 2021

The Role of Gut Microbiota in Lung Cancer: From Carcinogenesis to Immunotherapy

in Thoracic Oncology

Xiangjun Liu
Ye Cheng
Dan Zang
Min Zhang
Xiuhua Li
Dan Liu
Bing Gao
Huan Zhou
Jinzhe Sun
Xu Han

Frontiers in Oncology

doi 10.3389/fonc.2021.720842

15,174 views
58 citations

Mini Review

Published on 18 Aug 2021

Current Status of Immune Checkpoint Inhibitor Immunotherapy for Lung Cancer

in Thoracic Oncology

Wei Xiong
Yunfeng Zhao
He Du
Xuejun Guo

Frontiers in Oncology

doi 10.3389/fonc.2021.704336

9,780 views
32 citations

Original Research

Published on 17 Aug 2021

Cooperation Between Cancer and Fibroblasts in Vascular Mimicry and N2-Type Neutrophil Recruitment via Notch2–Jagged1 Interaction in Lung Cancer

in Thoracic Oncology

Ying-Ming Tsai
Kuan-Li Wu
Yu-Wei Liu
Wei-An Chang
Yung-Chi Huang
Chao-Yuan Chang
Pei-Hsun Tsai
Szi-Hui Liao
Jen-Yu Hung
Ya-Ling Hsu

Frontiers in Oncology

doi 10.3389/fonc.2021.696931

4,595 views
17 citations

Original Research

Published on 16 Aug 2021

Efficacy of EGFR-TKI Plus Chemotherapy or Monotherapy as First-Line Treatment for Advanced EGFR-Mutant Lung Adenocarcinoma Patients With Co-Mutations

in Thoracic Oncology

Zhengyu Yang
Ya Chen
Yanan Wang
Shuyuan Wang
Minjuan Hu
Bo Zhang
Baohui Han

Frontiers in Oncology

doi 10.3389/fonc.2021.681429

2,620 views
12 citations

Original Research

Published on 12 Aug 2021

Development and Validation of a Nomogram for Predicting Prognosis to Immune Checkpoint Inhibitors Plus Chemotherapy in Patients With Non-Small Cell Lung Cancer

in Thoracic Oncology

Hao Zeng
Wei-wei Huang
Yu-jie Liu
Qin Huang
Sheng-min Zhao
Ya-lun Li
Pan-wen Tian
Wei-min Li

Frontiers in Oncology

doi 10.3389/fonc.2021.685047

3,119 views
6 citations

Original Research

Published on 10 Aug 2021

EGFR DNA Methylation Correlates With EGFR Expression, Immune Cell Infiltration, and Overall Survival in Lung Adenocarcinoma

in Thoracic Oncology

Zhanyu Xu
Fanglu Qin
Liqiang Yuan
Jiangbo Wei
Yu Sun
Junqi Qin
Kun Deng
Tiaozhan Zheng
Shikang Li

Frontiers in Oncology

doi 10.3389/fonc.2021.691915

4,303 views
6 citations

Review

Published on 09 Aug 2021

Viral Infection and Lung Cancer Immunotherapy

in Thoracic Oncology

Ewa Kalinka
Izabela Chmielewska
Kamila Wojas-Krawczyk

Frontiers in Oncology

doi 10.3389/fonc.2021.577514

4,667 views
1 citation

Systematic Review

Published on 06 Aug 2021

Hepatoid Adenocarcinoma of the Lung: A Systematic Review of the Literature From 1981 to 2020

in Thoracic Oncology

Zan Hou
Jiaqing Xie
Li Zhang
Gangyi Dai
Yuanhang Chen
Lang He

Frontiers in Oncology

doi 10.3389/fonc.2021.702216

6,335 views
19 citations

Review

Published on 06 Aug 2021

Tryptophan and Its Metabolites in Lung Cancer: Basic Functions and Clinical Significance

in Thoracic Oncology

Chenwei Li
Hui Zhao

Frontiers in Oncology

doi 10.3389/fonc.2021.707277

4,818 views
20 citations

Systematic Review

Published on 03 Aug 2021

Intrapleural Administration With Rh-Endostatin and Chemical Irritants in the Control of Malignant Pleural Effusion: A Systematic Review and Meta-Analysis

in Thoracic Oncology

Cheng-Qiong Wang
Xiao-Rong Huang
Min He
Xiao-Tian Zheng
Hong Jiang
Qian Chen
Teng-Yan Fan
Lin Zhan
Juan Ling
Ji-Hong Feng

Frontiers in Oncology

doi 10.3389/fonc.2021.649999

2,886 views
4 citations

Original Research

Published on 29 Jul 2021

Real-World Efficacy and Safety of Anlotinib With and Without Immunotherapy in Advanced Non-Small Cell Lung Cancer

in Thoracic Oncology

Qi Xiong
Boyu Qin
Lingli Xin
Bo Yang
Qi Song
Yu Wang
Sujie Zhang
Yi Hu

Frontiers in Oncology

doi 10.3389/fonc.2021.659380

4,692 views
19 citations

Original Research

Published on 28 Jul 2021

Immune Microenvironment Signatures as Biomarkers to Predict Early Recurrence of Stage Ia-b Lung Cancer

in Thoracic Oncology

Qiang Wang
Danting Zhou
Fang Wu
Qingchun Liang
Qiongzhi He
Muyun Peng
Tianyu Yao
Yan Hu
Banglun Qian
Jingqun Tang

Frontiers in Oncology

doi 10.3389/fonc.2021.680287

4,141 views
21 citations

Review

Published on 27 Jul 2021

Carbon Nanotubes: A Summary of Beneficial and Dangerous Aspects of an Increasingly Popular Group of Nanomaterials

in Thoracic Oncology

Chengke Zhang
Licun Wu
Marc de Perrot
Xiaogang Zhao

Frontiers in Oncology

doi 10.3389/fonc.2021.693814

27,101 views
42 citations

Original Research

Published on 26 Jul 2021

KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials

in Thoracic Oncology

Hongyuan Zhu
Daipeng Xie
Yunfang Yu
Lintong Yao
Bin Xu
Luyu Huang
Shaowei Wu
Fasheng Li
Yating Zheng
Xinyi Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.659200

5,719 views
16 citations

Navigation group

Articles

Impact of Smoking History on Response to Immunotherapy in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

Targeted Therapy for RET Fusion Lung Cancer: Breakthrough and Unresolved Issue

The Role of Gut Microbiota in Lung Cancer: From Carcinogenesis to Immunotherapy

Current Status of Immune Checkpoint Inhibitor Immunotherapy for Lung Cancer

Cooperation Between Cancer and Fibroblasts in Vascular Mimicry and N2-Type Neutrophil Recruitment via Notch2–Jagged1 Interaction in Lung Cancer

Efficacy of EGFR-TKI Plus Chemotherapy or Monotherapy as First-Line Treatment for Advanced EGFR-Mutant Lung Adenocarcinoma Patients With Co-Mutations

Development and Validation of a Nomogram for Predicting Prognosis to Immune Checkpoint Inhibitors Plus Chemotherapy in Patients With Non-Small Cell Lung Cancer

EGFR DNA Methylation Correlates With EGFR Expression, Immune Cell Infiltration, and Overall Survival in Lung Adenocarcinoma

Viral Infection and Lung Cancer Immunotherapy

Hepatoid Adenocarcinoma of the Lung: A Systematic Review of the Literature From 1981 to 2020

Tryptophan and Its Metabolites in Lung Cancer: Basic Functions and Clinical Significance

Intrapleural Administration With Rh-Endostatin and Chemical Irritants in the Control of Malignant Pleural Effusion: A Systematic Review and Meta-Analysis

Real-World Efficacy and Safety of Anlotinib With and Without Immunotherapy in Advanced Non-Small Cell Lung Cancer

Immune Microenvironment Signatures as Biomarkers to Predict Early Recurrence of Stage Ia-b Lung Cancer

Carbon Nanotubes: A Summary of Beneficial and Dangerous Aspects of an Increasingly Popular Group of Nanomaterials

KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials